Related Experiment Video
Updated: Jun 23, 2026

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
Published on: August 16, 2024
From Gold to Polymer: Latex Bead-Assisted CRISPR-Cas12a Platform for Next-Generation Protein Diagnostics
Rana Jahani1, Jun Chen1, Juanhua Kong1
1Department of Chemistry, University of Missouri, Columbia, Missouri 65211, United States.
This study introduces a new CRISPR-Cas12a biosensor using latex beads for sensitive detection of interleukin-6 (IL-6). This approach offers a stable, specific, and cost-effective alternative to gold nanoparticles for early disease diagnosis.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Biotechnology
Background:
- Sensitive detection of protein biomarkers like interleukin-6 (IL-6) is vital for disease diagnosis and treatment monitoring.
- Existing gold nanoparticle (AuNP)-assisted CRISPR-Cas12a biosensors face challenges including high cost, aggregation, and nonspecific adsorption.
- There is a need for improved biosensing platforms for clinical applications.
Purpose of the Study:
- To develop a CRISPR-Cas12a-based fluorescence biosensor for detecting the inflammatory biomarker IL-6.
- To replace gold nanoparticles with latex beads as transducers and signal amplifiers in the biosensor.
- To evaluate the sensitivity, selectivity, and practical applicability of the novel biosensor.
Main Methods:
- Utilized a CRISPR-Cas12a system with dual-functionalized latex beads carrying IL-6 detection antibodies and dsDNA strands.
- Employed IL-6 antibody-functionalized magnetic beads for sample preparation and enrichment.
- Integrated latex beads as signal amplifiers for fluorescence detection.
Main Results:
- Achieved a highly sensitive limit of detection (LOD) for IL-6 as low as 0.76 pg/mL.
- Demonstrated excellent selectivity, with no interference from other proteins like HSA, BSA, CRP, PCT, and IL-2β.
- Successfully validated the biosensor's performance in analyzing simulated serum samples.
Conclusions:
- Latex beads are a viable and advantageous alternative to gold nanoparticles in CRISPR-based protein diagnostics.
- The developed biosensor offers improved stability and specificity while maintaining high sensitivity for IL-6 detection.
- This approach holds significant potential for early disease diagnosis and monitoring through enhanced protein biomarker analysis.
More Related Videos
09:03Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing